Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Knoff DS"'
Autor:
Knoff DS; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85721, United States., Kim S; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85721, United States., Fajardo Cortes KA; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85721, United States., Rivera J; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85721, United States., Cathey MVJ; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85721, United States., Altamirano D; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85721, United States., Camp C; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85721, United States., Kim M; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85721, United States.; Department of Materials Science and Engineering, University of Arizona, Tucson, Arizona 85721, United States.; BIO5 Institute, University of Arizona, Tucson, Arizona 85719, United States.
Publikováno v:
Biomacromolecules [Biomacromolecules] 2022 Oct 10; Vol. 23 (10), pp. 4130-4140. Date of Electronic Publication: 2022 Sep 23.
Autor:
Wang YC; Department of Chemistry and Biochemistry, University of Arizona, 1306 E University Boulevard, Tucson, Arizona 85721, USA. pembertn@email.arizona.edu., Kegel LL; Department of Chemistry and Biochemistry, University of Arizona, 1306 E University Boulevard, Tucson, Arizona 85721, USA. pembertn@email.arizona.edu., Knoff DS; Department of Biomedical Engineering, University of Arizona, 1127 E James E Rogers Way, Tucson, AZ 85721, USA., Deodhar BS; Department of Chemistry and Biochemistry, University of Arizona, 1306 E University Boulevard, Tucson, Arizona 85721, USA. pembertn@email.arizona.edu., Astashkin AV; Department of Chemistry and Biochemistry, University of Arizona, 1306 E University Boulevard, Tucson, Arizona 85721, USA. pembertn@email.arizona.edu., Kim M; Department of Biomedical Engineering, University of Arizona, 1127 E James E Rogers Way, Tucson, AZ 85721, USA.; Department of Materials Science and Engineering, University of Arizona, 1235 E James E Rogers Way, Tucson, AZ 85721, USA.; BIO5 Institute, University of Arizona, 1657 E Helen Street, Tucson, AZ 85721, USA., Pemberton JE; Department of Chemistry and Biochemistry, University of Arizona, 1306 E University Boulevard, Tucson, Arizona 85721, USA. pembertn@email.arizona.edu.
Publikováno v:
Journal of materials chemistry. B [J Mater Chem B] 2022 May 25; Vol. 10 (20), pp. 3861-3875. Date of Electronic Publication: 2022 May 25.
Autor:
Gandhi JK; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA., Heinrich L; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA., Knoff DS; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona, USA., Kim M; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona, USA.; Department of Materials Science, University of Arizona, Tucson, Arizona, USA.; BIO5 Institute, University of Arizona, Tucson, Arizona, USA., Marmorstein AD; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Publikováno v:
Journal of biomedical materials research. Part A [J Biomed Mater Res A] 2021 Nov; Vol. 109 (11), pp. 2357-2368. Date of Electronic Publication: 2021 May 11.
Autor:
Knoff DS; Department of Biomedical Engineering, University of Arizona, Tucson, AZ 85721., Szczublewski H; Department of Biomedical Engineering, University of Arizona, Tucson, AZ 85721., Altamirano D; Department of Biomedical Engineering, University of Arizona, Tucson, AZ 85721., Cortes KAF; Department of Biomedical Engineering, University of Arizona, Tucson, AZ 85721., Kim M; Department of Biomedical Engineering, University of Arizona, Tucson, AZ 85721.; Department of Materials Science and Engineering, University of Arizona, Tucson, AZ 85721.; BIO5 Institute, University of Arizona, Tucson, AZ 85719.
Publikováno v:
Macromolecules [Macromolecules] 2020 May 12; Vol. 53 (9), pp. 3464-3471. Date of Electronic Publication: 2020 Apr 29.
Autor:
Ulep TH; Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, 85721, United States., Zenhausern R; Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, 85721, United States., Gonzales A; Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, 85721, United States., Knoff DS; Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, 85721, United States., Lengerke Diaz PA; Hematology Oncology Division, Mayo Clinic, Phoenix, AZ, 85054, United States., Castro JE; Hematology Oncology Division, Mayo Clinic, Phoenix, AZ, 85054, United States., Yoon JY; Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, 85721, United States. Electronic address: jyyoon@email.arizona.edu.
Publikováno v:
Biosensors & bioelectronics [Biosens Bioelectron] 2020 Apr 01; Vol. 153, pp. 112042. Date of Electronic Publication: 2020 Jan 22.
Autor:
Camp CP; Department of Biomedical Engineering, University of Arizona, Tucson, AZ, United States., Peterson IL; Applied Biosciences GIDP, University of Arizona, Tucson, AZ, United States.; BIO5 Institute, University of Arizona, Tucson, AZ, United States., Knoff DS; Department of Biomedical Engineering, University of Arizona, Tucson, AZ, United States., Melcher LG; BIO5 Institute, University of Arizona, Tucson, AZ, United States., Maxwell CJ; Department of Biomedical Engineering, University of Arizona, Tucson, AZ, United States., Cohen AT; Department of Biomedical Engineering, University of Arizona, Tucson, AZ, United States., Wertheimer AM; Applied Biosciences GIDP, University of Arizona, Tucson, AZ, United States.; BIO5 Institute, University of Arizona, Tucson, AZ, United States., Kim M; Department of Biomedical Engineering, University of Arizona, Tucson, AZ, United States.; BIO5 Institute, University of Arizona, Tucson, AZ, United States.; Department of Materials Science & Engineering, University of Arizona, Tucson, AZ, United States.
Publikováno v:
Frontiers in chemistry [Front Chem] 2020 Mar 13; Vol. 8, pp. 173. Date of Electronic Publication: 2020 Mar 13 (Print Publication: 2020).
Autor:
Lee T; Department of Materials Science and Engineering, University of Arizona, Tucson, AZ 85721, USA., Park J; Department of Mining and Geological Engineering, University of Arizona, Tucson, AZ 85721, USA., Knoff DS; Department of Biomedical Engineering, University of Arizona, Tucson, AZ 85721, USA., Kim K; Department of Mining and Geological Engineering, University of Arizona, Tucson, AZ 85721, USA., Kim M; Department of Materials Science and Engineering, University of Arizona, Tucson, AZ 85721, USA.; Department of Biomedical Engineering, University of Arizona, Tucson, AZ 85721, USA.; BIO5 Institute, University of Arizona, Tucson, AZ 85719, USA.
Publikováno v:
RSC advances [RSC Adv] 2019; Vol. 9 (68), pp. 40146-40151. Date of Electronic Publication: 2019 Dec 03.
Autor:
Stevens MM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Maire CL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Chou N; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Murakami MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Knoff DS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Kikuchi Y; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Hitachi High-Technologies Corporation, Ibaraki-ken, Japan., Kimmerling RJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Liu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Haidar S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Calistri NL; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Cermak N; Program in Computational and Systems Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Olcum S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Cordero NA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Idbaih A; Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France.; AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France., Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute, Cambridge, Massachusetts, USA., Ligon KL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute, Cambridge, Massachusetts, USA.; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Manalis SR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2016 Nov; Vol. 34 (11), pp. 1161-1167. Date of Electronic Publication: 2016 Oct 10.
Autor:
Miller MB; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ramkissoon LA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kang YJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Abedalthagafi M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Knoff DS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Agarwalla PK; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA., Wen PY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Reardon DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Alexander BM; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Laws ER Jr; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Dunn IF; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Beroukhim R; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Ligon KL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ramkissoon SH; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2016 Jun 14; Vol. 7 (24), pp. 37054-37063.
Autor:
Green AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Ramkissoon SH; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., McCauley D; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Jones K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Perry JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Hsu JH; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Ramkissoon LA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Maire CL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Hubbell-Engler B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Knoff DS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Shacham S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Ligon KL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.)., Kung AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (A.L.G., J.A.P., J.H.-R.H., B.H.-E.); Division of Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts (A.L.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., C.L.M., D.S.K., K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Karyopharm Therapeutics, Natick, Massachusetts (D.M., S.S.); Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts (K.J.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pediatrics, Columbia University Medical Center, New York, New York (A.L.K.).
Publikováno v:
Neuro-oncology [Neuro Oncol] 2015 May; Vol. 17 (5), pp. 697-707. Date of Electronic Publication: 2014 Nov 02.